CLINICAL_TRIALS
trial_result
· 2019-09-06
Clinical Trial Update: Phase l/II Study of Ruxolitinib for Acute Leukemia [Phase 1, Phase 2]
Summary
A Phase I/II study of ruxolitinib in acute leukemia was terminated, and trial results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-09-06